2
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
118
Neoplasms
110
Lung Neoplasms
65
Colorectal Neoplasms
52
Prostatic Neoplasms
46
Carcinoma, Non-Small-Cell Lung
46
Pancreatic Neoplasms
34
Melanoma
33
Ovarian Neoplasms
29
Neoplastic Cells, Circulating
29
Head and Neck Neoplasms
27
Uterine Cervical Neoplasms
23
Multiple Myeloma
20
Glioma
20
Colonic Neoplasms
20
Sarcoma
19
Carcinoma, Hepatocellular
19
Leukemia, Myeloid, Acute
18
Neoplasm Metastasis
17
Lymphoma
15
Glioblastoma
15
Esophageal Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
14
Hematologic Neoplasms
14
Leukemia
13
Endometrial Neoplasms
13
Myelodysplastic Syndromes
11
Kidney Neoplasms
11
Gastrointestinal Neoplasms
11
Carcinoma, Renal Cell
11
Interventions
Temozolomide
26
Magnetic Resonance Spectroscopy
19
Etoposide
14
Cyclophosphamide
13
Radiotherapy
11
Filgrastim
10
Bevacizumab
10
Carboplatin
9
Biopsy
8
Cisplatin
7
X-Rays
6
Thiotepa
6
Specimen Handling
6
Phantoms, Imaging
6
Carmustine
6
Radiation
5
Nuclear Medicine Department, Hospital
5
Nivolumab
5
Irinotecan
5
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
5
sargramostim
4
Vincristine
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
Erlotinib Hydrochloride
4
Azacitidine
4
etoposide phosphate
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Lapatinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ependymoma
×
Blood Specimen Collection
×
Clear all
NCT06323408
2025-03-25
BZKF-AYA
University Hospital Regensburg
Not yet recruiting
72 enrolled